Urology trial goes e-PRO

A large--but unnamed--drugmaker conducting a Phase II trial for a urology treatment will use electronic diaries to collect patient-reported outcome data. The 750-subject trial spans 22 countries on three continents and requires use of 34 languages, according to an announcement.

The sponsor selected the etrials eDiary 5.0 platform from Merge Healthcare. The manufacturer's eDiary Inventory Module, for tracking the shipping and supply of study data-capture devices, will also be used.

The eDiary 5.0 software, based on the Windows Mobile operating system, runs a ruggedized handheld device, the manufacturer says. Patients enter outcomes data using the device and then upload the data to a centralized electronic repository, where it is accessible to trial managers in real time.

- here's the announcement

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.